A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers (NCT06878170)

🧪 Interventions in This Study

• RBM-001 (BIOLOGICAL)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• QPS Miami — Miami, Florida

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in COVID-19

• COVID-19 and Cancer Consortium Registry — Nashville, Tennessee
• Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients — Sacramento, California
• COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE) — Bethesda, Maryland
• Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans — Baltimore, Maryland
• Canadian Adaptive Platform Trial of Treatments for COVID-19 in Community Settings — Calgary, Alberta
• A Nasal Treatment for COVID-19 — Indianapolis, Indiana

Explore by condition: All COVID-19 clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.